Activated Protein C for Ischemic Central Retinal Vein Occlusion: One-Year Results.
Intravitreally administered activated protein C in 10 eyes with ischemic central retinal vein occlusion significantly improved macular edema; in 5 eyes, the reperfusion of the retinal nonperfused areas exceeded 50% of baseline.